Frédéric Massé
Impact in
- Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Bone Metabolism and Diseases 9
- Natural product bioactivities and synthesis 5
- Metabolism, Diabetes, and Cancer 4
- Enzyme function and inhibition 2
-
- Protease and Inhibitor Mechanisms 8
- Co-authors
- W. Cameron Black (12 shared papers)Raphaël Roduit (3 shared papers)Marc Prentki (3 shared papers)Sylvie Desmarais (9 shared papers)M. David Percival (8 shared papers)Jean‐Pierre Falgueyret (6 shared papers)Neil B. Ruderman (2 shared papers)Denis Riendeau (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Medicinal Chemistry (3 papers)Journal of Biological Chemistry (2 papers)Computational and Structural Biotechnology Journal (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Frédéric Massé
22 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 130
- Cancer Research 191
- Organic Chemistry 363
- Molecular Biology 717
- Pharmacology 147
Countries citing papers authored by Frédéric Massé
This map shows the geographic impact of Frédéric Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Massé more than expected).
Fields of papers citing papers by Frédéric Massé
This network shows the impact of papers produced by Frédéric Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Massé. The network helps show where Frédéric Massé may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Massé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 166 | |
| 2 | 2000 | 156 | |
| 3 | 2000 | 141 | |
| 4 | 2005 | 121 | |
| 5 | 2005 | 118 | |
| 6 | 2007 | 118 | |
| 7 | 2013 | 79 | |
| 8 | 2006 | 72 | |
| 9 | 2010 | 71 | |
| 10 | 2009 | 56 | |
| 11 | 2010 | 55 | |
| 12 | 2007 | 52 | |
| 13 | 2009 | 41 | |
| 14 | 2006 | 31 | |
| 15 | 2007 | 30 | |
| 16 | 2008 | 23 | |
| 17 | 2008 | 22 | |
| 18 | 2011 | 22 | |
| 19 | 2005 | 14 | |
| 20 | 2007 | 11 |
About Frédéric Massé
Frédéric Massé is a scholar working on Molecular Biology, Cancer Research, Surgery, Physiology and Immunology and Allergy, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (9 papers), Protease and Inhibitor Mechanisms (8 papers), Natural product bioactivities and synthesis (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Cell Adhesion Molecules Research (3 papers), Trypanosoma species research and implications (2 papers), Research on Leishmaniasis Studies (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Pharmaceutical Science (130 citations), Cancer Research (191 citations), Organic Chemistry (363 citations), Molecular Biology (717 citations) and Pharmacology (147 citations). Frédéric Massé has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include W. Cameron Black, Raphaël Roduit, Marc Prentki, Sylvie Desmarais, M. David Percival, Jean‐Pierre Falgueyret, Neil B. Ruderman, Denis Riendeau, Serge Léger and Renata M. Oballa. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Computational and Structural Biotechnology Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.